IRVINE, Calif. --Advanced Sterilization Products (ASP), a Johnson & Johnson company, today announced that its Cidex OPA Solution has received Food and Drug Administration (FDA) 510(k) marketing clearance for a five-minute processing time when used in automatic endoscope reprocessors at a minimum of 25 degrees C
(77 degrees F).
This reduction in processing time -- from 12 to 5 minutes -- makes Cidex OPA Solution the fastest non-glutaraldehyde high-level disinfectant available for medical device reprocessing.
Cidex OPA Solution, a low vapor and low odor solution, is designed to be compatible with a wide range of endoscopes and medical devices. Its ease of use and shortened processing time allow high-volume patient-care areas, such as GI labs, to avoid delays in procedures and decrease inventory costs by rapid throughput of endoscopes and medical
instrumentation.
Santi Corsaro, worldwide president of ASP, said that Cidex OPA Solution has been well received since its U.S. launch in 1999. "Almost half of American hospitals today safely, effectively, and conveniently utilize the solution as part of their instrument processing practice," Corsaro said. "Cidex OPA Solution now allows healthcare facilities to reduce instrument processing time up to 75 percent compared with traditional glutaraldehyde disinfectants, improving staff efficiency and eliminating the need for redundant instruments."
Medical facilities can also manually process instruments in Cidex OPA Solution -- it provides high-level disinfection with a 12-minute soak time at room temperature (20 degrees C) -- increasing efficiency by allowing facilities to standardize their use of high- level disinfectants.
Cidex OPA Solution requires no activation or mixing and has a 14-day reuse life, a 75-day open-bottle life, and a two-year shelf life. Cidex OPA Solution is a proprietary formulation that destroys 100 percent of Mycobacterium tuberculosis.
Advanced Sterilization Products (ASP), a Johnson & Johnson company, a division of Ethicon, Inc., manufactures and markets a wide range of innovative sterilization, disinfection, and cleaning technologies. The company is committed to providing safe, effective and economically sound solutions that meet the needs of healthcare providers.
AHE Exchange Summit 2025 Brings EVS and Infection Prevention Experts Together in Columbus, Ohio
June 9th 2025The Association for the Health Care Environment (AHE) is set to host its largest event of the year—Exchange Summit 2025—from June 8 to 11 in Columbus, Ohio. With over 600 environmental services (EVS) professionals expected to attend, this year’s conference focuses heavily on infection prevention, interdepartmental collaboration, and education that empowers frontline health care support leaders to improve patient safety and operational efficiency.
Far UV-C Light Shows Promise for Decontaminating Medical Equipment in Clinical Settings
June 4th 2025Manual cleaning gaps on shared hospital equipment can undermine infection control efforts. New research shows far UV-C light can serve as a safe, automated backup to reduce contamination in real-world clinical settings.
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.